Infection not associated with use of human musculoskeletal tissue allografts.
The deaths of otherwise healthy patients that are attributable to contaminated allografts have heightened concerns about the screening, processing, and use of such tissues. We present one tertiary care institution's experience with musculoskeletal allografts and determine the frequency of postoperative Clostridium infection. We used an institutional microbiology database to identify all records of culture-confirmed Clostridium infection from January 1990 through July 2006. A comprehensive musculoskeletal database was cross-referenced to include all possible allograft samples surgically collected or implanted from January 1990 through July 2004 to determine the frequency of Clostridium infection associated with use of allograft musculoskeletal tissue. Musculoskeletal allografts were implanted in 16,314 patients during the study period. After a minimum follow-up of 2 years, no patient had development of a definite Clostridium infection that was attributable to the use of musculoskeletal allograft tissue. These outcomes can be achieved with established screening and processing techniques for donor tissue.
Eastlack
Robert K
RK
Department of Orthopedic Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Kesman
Thomas J
TJ
Patel
Robin
R
Huddleston
Paul M
PM
D003015:Clostridium Infections / Q000209:etiology*; D006801:Humans; D009141:Musculoskeletal System / Q000382:microbiology*; D016378:Tissue Transplantation / Q000009:adverse effects*; D020858:Tissue and Organ Harvesting; D014184:Transplantation, Homologous